Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy.
Identifieur interne : 001494 ( PubMed/Curation ); précédent : 001493; suivant : 001495Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy.
Auteurs : Dale L. Barnard [États-Unis] ; Yohichi KumakiSource :
- Future virology [ 1746-0794 ] ; 2011.
Abstract
Severe acute respiratory syndrome coronavirus (SARS-CoV) emerged in early 2003 to cause a very severe acute respiratory syndrome, which eventually resulted in a 10% case-fatality rate. Owing to excellent public health measures that isolated focus cases and their contacts, and the use of supportive therapies, the epidemic was suppressed to the point that further cases have not appeared since 2005. However, despite intensive research since then (over 3500 publications), it remains an untreatable disease. The potential for re-emergence of the SARS-CoV or a similar virus with unknown but potentially serious consequences remains high. This is due in part to the extreme genetic variability of RNA viruses such as the coronaviruses, the many animal reservoirs that seem to be able host the SARS-CoV in which reassortment or recombination events could occur and the ability coronaviruses have to transmit relatively rapidly from species to species in a short period of time. Thus, it seems prudent to continue to explore and develop antiviral chemotherapies to treat SARS-CoV infections. To this end, the various efficacious anti-SARS-CoV therapies recently published from 2007 to 2010 are reviewed in this article. In addition, compounds that have been tested in various animal models and were found to reduce virus lung titers and/or were protective against death in lethal models of disease, or otherwise have been shown to ameliorate the effects of viral infection, are also reported.
DOI: 10.2217/fvl.11.33
PubMed: 21765859
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001494
Links to Exploration step
pubmed:21765859Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy.</title><author><name sortKey="Barnard, Dale L" sort="Barnard, Dale L" uniqKey="Barnard D" first="Dale L" last="Barnard">Dale L. Barnard</name><affiliation wicri:level="1"><nlm:affiliation>Utah State University, Institute for Antiviral Research, Department of Animal, Dairy & Veterinary Science, 5600 Old Main Hill, Logan, UT 84322, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Utah State University, Institute for Antiviral Research, Department of Animal, Dairy & Veterinary Science, 5600 Old Main Hill, Logan, UT 84322</wicri:regionArea></affiliation></author><author><name sortKey="Kumaki, Yohichi" sort="Kumaki, Yohichi" uniqKey="Kumaki Y" first="Yohichi" last="Kumaki">Yohichi Kumaki</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="RBID">pubmed:21765859</idno><idno type="pmid">21765859</idno><idno type="doi">10.2217/fvl.11.33</idno><idno type="wicri:Area/PubMed/Corpus">001494</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001494</idno><idno type="wicri:Area/PubMed/Curation">001494</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001494</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy.</title><author><name sortKey="Barnard, Dale L" sort="Barnard, Dale L" uniqKey="Barnard D" first="Dale L" last="Barnard">Dale L. Barnard</name><affiliation wicri:level="1"><nlm:affiliation>Utah State University, Institute for Antiviral Research, Department of Animal, Dairy & Veterinary Science, 5600 Old Main Hill, Logan, UT 84322, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Utah State University, Institute for Antiviral Research, Department of Animal, Dairy & Veterinary Science, 5600 Old Main Hill, Logan, UT 84322</wicri:regionArea></affiliation></author><author><name sortKey="Kumaki, Yohichi" sort="Kumaki, Yohichi" uniqKey="Kumaki Y" first="Yohichi" last="Kumaki">Yohichi Kumaki</name></author></analytic><series><title level="j">Future virology</title><idno type="ISSN">1746-0794</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Severe acute respiratory syndrome coronavirus (SARS-CoV) emerged in early 2003 to cause a very severe acute respiratory syndrome, which eventually resulted in a 10% case-fatality rate. Owing to excellent public health measures that isolated focus cases and their contacts, and the use of supportive therapies, the epidemic was suppressed to the point that further cases have not appeared since 2005. However, despite intensive research since then (over 3500 publications), it remains an untreatable disease. The potential for re-emergence of the SARS-CoV or a similar virus with unknown but potentially serious consequences remains high. This is due in part to the extreme genetic variability of RNA viruses such as the coronaviruses, the many animal reservoirs that seem to be able host the SARS-CoV in which reassortment or recombination events could occur and the ability coronaviruses have to transmit relatively rapidly from species to species in a short period of time. Thus, it seems prudent to continue to explore and develop antiviral chemotherapies to treat SARS-CoV infections. To this end, the various efficacious anti-SARS-CoV therapies recently published from 2007 to 2010 are reviewed in this article. In addition, compounds that have been tested in various animal models and were found to reduce virus lung titers and/or were protective against death in lethal models of disease, or otherwise have been shown to ameliorate the effects of viral infection, are also reported.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">21765859</PMID><DateRevised><Year>2019</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1746-0794</ISSN><JournalIssue CitedMedium="Print"><Volume>6</Volume><Issue>5</Issue><PubDate><Year>2011</Year><Month>May</Month></PubDate></JournalIssue><Title>Future virology</Title><ISOAbbreviation>Future Virol</ISOAbbreviation></Journal><ArticleTitle>Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy.</ArticleTitle><Pagination><MedlinePgn>615-631</MedlinePgn></Pagination><Abstract><AbstractText>Severe acute respiratory syndrome coronavirus (SARS-CoV) emerged in early 2003 to cause a very severe acute respiratory syndrome, which eventually resulted in a 10% case-fatality rate. Owing to excellent public health measures that isolated focus cases and their contacts, and the use of supportive therapies, the epidemic was suppressed to the point that further cases have not appeared since 2005. However, despite intensive research since then (over 3500 publications), it remains an untreatable disease. The potential for re-emergence of the SARS-CoV or a similar virus with unknown but potentially serious consequences remains high. This is due in part to the extreme genetic variability of RNA viruses such as the coronaviruses, the many animal reservoirs that seem to be able host the SARS-CoV in which reassortment or recombination events could occur and the ability coronaviruses have to transmit relatively rapidly from species to species in a short period of time. Thus, it seems prudent to continue to explore and develop antiviral chemotherapies to treat SARS-CoV infections. To this end, the various efficacious anti-SARS-CoV therapies recently published from 2007 to 2010 are reviewed in this article. In addition, compounds that have been tested in various animal models and were found to reduce virus lung titers and/or were protective against death in lethal models of disease, or otherwise have been shown to ameliorate the effects of viral infection, are also reported.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barnard</LastName><ForeName>Dale L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Utah State University, Institute for Antiviral Research, Department of Animal, Dairy & Veterinary Science, 5600 Old Main Hill, Logan, UT 84322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumaki</LastName><ForeName>Yohichi</ForeName><Initials>Y</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>N01AI15435</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>N01AI30048</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HHSN272201000039I</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>N01 AI015435</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>N01 AI030048</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Future Virol</MedlineTA><NlmUniqueID>101278124</NlmUniqueID><ISSNLinking>1746-0794</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21765859</ArticleId><ArticleId IdType="doi">10.2217/fvl.11.33</ArticleId><ArticleId IdType="pmc">PMC3136164</ArticleId><ArticleId IdType="mid">NIHMS304163</ArticleId></ArticleIdList><pmc-dir>nihms</pmc-dir>
<ReferenceList><Reference><Citation>J Virol. 2004 Sep;78(18):9977-86</Citation><ArticleIdList><ArticleId IdType="pubmed">15331731</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2006 Feb 10;281(6):3198-203</Citation><ArticleIdList><ArticleId IdType="pubmed">16339146</ArticleId></ArticleIdList></Reference><Reference><Citation>Antivir Ther. 2007;12(4 Pt B):639-50</Citation><ArticleIdList><ArticleId IdType="pubmed">17944271</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2009 Sep 23;4(9):e7142</Citation><ArticleIdList><ArticleId IdType="pubmed">19774076</ArticleId></ArticleIdList></Reference><Reference><Citation>Antiviral Res. 2007 Sep;75(3):179-87</Citation><ArticleIdList><ArticleId IdType="pubmed">17428553</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Biochem Biophys. 2007 Oct 1;466(1):8-14</Citation><ArticleIdList><ArticleId IdType="pubmed">17692280</ArticleId></ArticleIdList></Reference><Reference><Citation>Viral Immunol. 2007 Sep;20(3):495-502</Citation><ArticleIdList><ArticleId IdType="pubmed">17931120</ArticleId></ArticleIdList></Reference><Reference><Citation>Virus Res. 2008 Apr;133(1):20-32</Citation><ArticleIdList><ArticleId IdType="pubmed">17499378</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2005 Sep;11(9):944-51</Citation><ArticleIdList><ArticleId IdType="pubmed">16116432</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2006 Mar 1;193(5):685-92</Citation><ArticleIdList><ArticleId IdType="pubmed">16453264</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12540-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16894145</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Biochem Biophys. 2007 Mar 15;459(2):197-207</Citation><ArticleIdList><ArticleId IdType="pubmed">17306213</ArticleId></ArticleIdList></Reference><Reference><Citation>Scand J Infect Dis. 2011 Jul;43(6-7):515-21</Citation><ArticleIdList><ArticleId IdType="pubmed">21366405</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2011 May;85(9):4122-34</Citation><ArticleIdList><ArticleId IdType="pubmed">21325420</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2007 Apr;81(8):4012-20</Citation><ArticleIdList><ArticleId IdType="pubmed">17267506</ArticleId></ArticleIdList></Reference><Reference><Citation>Antiviral Res. 2010 Mar;85(3):551-5</Citation><ArticleIdList><ArticleId IdType="pubmed">19995578</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2010 Nov;84(21):11336-49</Citation><ArticleIdList><ArticleId IdType="pubmed">20686038</ArticleId></ArticleIdList></Reference><Reference><Citation>Antiviral Res. 2007 Mar;73(3):219-27</Citation><ArticleIdList><ArticleId IdType="pubmed">17112601</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rep Med Chem. 2007 Feb 1;41:183-196</Citation><ArticleIdList><ArticleId IdType="pubmed">19649165</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Pulm Med. 2008 May;14(3):248-53</Citation><ArticleIdList><ArticleId IdType="pubmed">18427249</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2009 Dec 20;395(2):210-22</Citation><ArticleIdList><ArticleId IdType="pubmed">19853271</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2007 Apr;81(8):3913-21</Citation><ArticleIdList><ArticleId IdType="pubmed">17229691</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 2005 Apr 29;330(1):286-92</Citation><ArticleIdList><ArticleId IdType="pubmed">15781262</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Disord Drug Targets. 2009 Apr;9(2):223-45</Citation><ArticleIdList><ArticleId IdType="pubmed">19275708</ArticleId></ArticleIdList></Reference><Reference><Citation>Antiviral Res. 2007 Oct;76(1):21-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17560666</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Immunopharmacol. 2007 Mar;7(3):392-400</Citation><ArticleIdList><ArticleId IdType="pubmed">17276898</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 2008 Jun 20;371(1):110-3</Citation><ArticleIdList><ArticleId IdType="pubmed">18406349</ArticleId></ArticleIdList></Reference><Reference><Citation>Virus Res. 2008 Apr;133(1):74-87</Citation><ArticleIdList><ArticleId IdType="pubmed">17451830</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2006 Mar 1;346(1):74-85</Citation><ArticleIdList><ArticleId IdType="pubmed">16303160</ArticleId></ArticleIdList></Reference><Reference><Citation>Protein Expr Purif. 2005 Jun;41(2):235-40</Citation><ArticleIdList><ArticleId IdType="pubmed">15866708</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Exp Med Biol. 2006;581:37-41</Citation><ArticleIdList><ArticleId IdType="pubmed">17037501</ArticleId></ArticleIdList></Reference><Reference><Citation>Protein Eng Des Sel. 2008 Aug;21(8):495-505</Citation><ArticleIdList><ArticleId IdType="pubmed">18480090</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2006 Jul;3(7):e237</Citation><ArticleIdList><ArticleId IdType="pubmed">16796401</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2007 Dec 5;369(1):206-13</Citation><ArticleIdList><ArticleId IdType="pubmed">17761207</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1951-2</Citation><ArticleIdList><ArticleId IdType="pubmed">12748315</ArticleId></ArticleIdList></Reference><Reference><Citation>Handb Exp Pharmacol. 2009;(189):85-110</Citation><ArticleIdList><ArticleId IdType="pubmed">19048198</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Pathog. 2010 Nov 04;6(11):e1001176</Citation><ArticleIdList><ArticleId IdType="pubmed">21079686</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2005 Sep;19(3):207-10</Citation><ArticleIdList><ArticleId IdType="pubmed">16261198</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2005 Oct 28;310(5748):676-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16195424</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioorg Med Chem. 2005 Sep 1;13(17):5240-52</Citation><ArticleIdList><ArticleId IdType="pubmed">15994085</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2005 Mar;11(3):446-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15757562</ArticleId></ArticleIdList></Reference><Reference><Citation>Vopr Virusol. 2008 Jul-Aug;53(4):9-13</Citation><ArticleIdList><ArticleId IdType="pubmed">18756809</ArticleId></ArticleIdList></Reference><Reference><Citation>Antiviral Res. 2011 Jan;89(1):75-82</Citation><ArticleIdList><ArticleId IdType="pubmed">21093489</ArticleId></ArticleIdList></Reference><Reference><Citation>J Antimicrob Chemother. 2008 Sep;62(3):437-41</Citation><ArticleIdList><ArticleId IdType="pubmed">18565970</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2003 May 30;300(5624):1399-404</Citation><ArticleIdList><ArticleId IdType="pubmed">12730501</ArticleId></ArticleIdList></Reference><Reference><Citation>J Transl Med. 2007 Feb 12;5:10</Citation><ArticleIdList><ArticleId IdType="pubmed">17295916</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2004 Jun 26;363(9427):2139-41</Citation><ArticleIdList><ArticleId IdType="pubmed">15220038</ArticleId></ArticleIdList></Reference><Reference><Citation>FEBS Lett. 2006 May 15;580(11):2577-83</Citation><ArticleIdList><ArticleId IdType="pubmed">16647061</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2005 May;79(9):5833-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15827197</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Pharm Des. 2006;12(35):4539-53</Citation><ArticleIdList><ArticleId IdType="pubmed">17168760</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Top Med Chem. 2006;6(4):361-76</Citation><ArticleIdList><ArticleId IdType="pubmed">16611148</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2003 Oct 30;425(6961):915</Citation><ArticleIdList><ArticleId IdType="pubmed">14586458</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2005 Dec;79(24):15199-208</Citation><ArticleIdList><ArticleId IdType="pubmed">16306591</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Genet Evol. 2009 Dec;9(6):1185-96</Citation><ArticleIdList><ArticleId IdType="pubmed">19800030</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Cell Mol Biol. 2004 Mar;30(3):251-60</Citation><ArticleIdList><ArticleId IdType="pubmed">14969997</ArticleId></ArticleIdList></Reference><Reference><Citation>Antiviral Res. 2008 Aug;79(2):105-13</Citation><ArticleIdList><ArticleId IdType="pubmed">18423639</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2010 Mar;84(5):2511-21</Citation><ArticleIdList><ArticleId IdType="pubmed">20032190</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Microbiol. 2009 Mar;7(3):226-36</Citation><ArticleIdList><ArticleId IdType="pubmed">19198616</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 Jul 26;362(9380):293-4</Citation><ArticleIdList><ArticleId IdType="pubmed">12892961</ArticleId></ArticleIdList></Reference><Reference><Citation>Respir Med. 2003 Apr;97(4):382-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12693798</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2010 Jan;84(2):1097-109</Citation><ArticleIdList><ArticleId IdType="pubmed">19889773</ArticleId></ArticleIdList></Reference><Reference><Citation>J Struct Funct Genomics. 2007 Sep;8(2-3):85-97</Citation><ArticleIdList><ArticleId IdType="pubmed">17680348</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong Kong Med J. 2009 Jun;15(3 Suppl 4):28-31</Citation><ArticleIdList><ArticleId IdType="pubmed">19509435</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Top Microbiol Immunol. 2007;315:325-44</Citation><ArticleIdList><ArticleId IdType="pubmed">17848070</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Virol. 2007 Oct;79(10 ):1431-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17705188</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2006 Aug;80(15):7287-94</Citation><ArticleIdList><ArticleId IdType="pubmed">16840309</ArticleId></ArticleIdList></Reference><Reference><Citation>MAbs. 2010 Jan-Feb;2(1):53-66</Citation><ArticleIdList><ArticleId IdType="pubmed">20168090</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Opin Ther Pat. 2009 Mar;19(3):357-67</Citation><ArticleIdList><ArticleId IdType="pubmed">19449500</ArticleId></ArticleIdList></Reference><Reference><Citation>J Antimicrob Chemother. 2007 Oct;60(4):741-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17704516</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2005 Mar 11;280(10):9345-53</Citation><ArticleIdList><ArticleId IdType="pubmed">15613479</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong Kong Med J. 2008 Aug;14 Suppl 4:36-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18708673</ArticleId></ArticleIdList></Reference><Reference><Citation>Proteomics. 2007 May;7(9):1446-60</Citation><ArticleIdList><ArticleId IdType="pubmed">17407183</ArticleId></ArticleIdList></Reference><Reference><Citation>FEBS Lett. 2003 Oct 23;553(3):451-6</Citation><ArticleIdList><ArticleId IdType="pubmed">14572668</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pharm Pharm Sci. 2008 Apr 19;11(2):1s-13s</Citation><ArticleIdList><ArticleId IdType="pubmed">19203466</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Pathog. 2010 Feb 05;6(2):e1000756</Citation><ArticleIdList><ArticleId IdType="pubmed">20140198</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Mol Biol. 2008;442:139-58</Citation><ArticleIdList><ArticleId IdType="pubmed">18369784</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1997 Feb 20;385(6618):729-33</Citation><ArticleIdList><ArticleId IdType="pubmed">9034190</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Biol Toxicol. 2006 Sep;22(5):313-22</Citation><ArticleIdList><ArticleId IdType="pubmed">16845612</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2003 Jun 13;300(5626):1763-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12746549</ArticleId></ArticleIdList></Reference><Reference><Citation>Antiviral Res. 2006 Aug;71(1):53-63</Citation><ArticleIdList><ArticleId IdType="pubmed">16621037</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Chem. 2010 Jul 8;53(13):4968-79</Citation><ArticleIdList><ArticleId IdType="pubmed">20527968</ArticleId></ArticleIdList></Reference><Reference><Citation>Chem Commun (Camb). 2007 Nov 14;(42):4413-5</Citation><ArticleIdList><ArticleId IdType="pubmed">17957304</ArticleId></ArticleIdList></Reference><Reference><Citation>Antivir Chem Chemother. 2010 Mar 09;20(4):169-77</Citation><ArticleIdList><ArticleId IdType="pubmed">20231782</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2007 Jan;81(2):718-31</Citation><ArticleIdList><ArticleId IdType="pubmed">17079322</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Dis Clin North Am. 2010 Mar;24(1):175-202</Citation><ArticleIdList><ArticleId IdType="pubmed">20171552</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16119-24</Citation><ArticleIdList><ArticleId IdType="pubmed">18852458</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2004 Sep 15;173(6):4030-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15356152</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2008 Feb;82(4):1819-26</Citation><ArticleIdList><ArticleId IdType="pubmed">18057240</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Dis Clin North Am. 2010 Sep;24(3):619-38</Citation><ArticleIdList><ArticleId IdType="pubmed">20674795</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2005 Jan;79(1):503-11</Citation><ArticleIdList><ArticleId IdType="pubmed">15596843</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2004 Jun;78(11):5619-32</Citation><ArticleIdList><ArticleId IdType="pubmed">15140959</ArticleId></ArticleIdList></Reference><Reference><Citation>Structure. 2004 Feb;12(2):341-53</Citation><ArticleIdList><ArticleId IdType="pubmed">14962394</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2005 Aug 26;280(34):30113-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15983030</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioorg Med Chem Lett. 2008 Oct 15;18(20):5684-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18796354</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2009 Jun 26;284(26):17512-20</Citation><ArticleIdList><ArticleId IdType="pubmed">19364769</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Med Chem. 2008;15(10):997-1005</Citation><ArticleIdList><ArticleId IdType="pubmed">18393857</ArticleId></ArticleIdList></Reference><Reference><Citation>Virol J. 2010 Feb 09;7:31</Citation><ArticleIdList><ArticleId IdType="pubmed">20144233</ArticleId></ArticleIdList></Reference><Reference><Citation>J Ethnopharmacol. 2008 Oct 30;120(1):108-11</Citation><ArticleIdList><ArticleId IdType="pubmed">18762235</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2005 Aug;11(8):875-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16007097</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 2006 Oct 18;25(20):4933-42</Citation><ArticleIdList><ArticleId IdType="pubmed">17024178</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Biol. 2007 May 11;368(4):1075-86</Citation><ArticleIdList><ArticleId IdType="pubmed">17379242</ArticleId></ArticleIdList></Reference><Reference><Citation>Antivir Chem Chemother. 2006;17(5):275-84</Citation><ArticleIdList><ArticleId IdType="pubmed">17176632</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2003 May 30;300(5624):1394-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12730500</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2004 Sep;10(9):927-34</Citation><ArticleIdList><ArticleId IdType="pubmed">15311275</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann N Y Acad Sci. 2007 Apr;1102:26-38</Citation><ArticleIdList><ArticleId IdType="pubmed">17470909</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Pharm Des. 2006;12(35):4573-90</Citation><ArticleIdList><ArticleId IdType="pubmed">17168763</ArticleId></ArticleIdList></Reference><Reference><Citation>Angew Chem Int Ed Engl. 2007;46(34):6464-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17645269</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Pathog. 2007 Jan;3(1):e5</Citation><ArticleIdList><ArticleId IdType="pubmed">17222058</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1999 Oct 15;286(5439):498-502</Citation><ArticleIdList><ArticleId IdType="pubmed">10521339</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2007 Feb;81(4):1701-13</Citation><ArticleIdList><ArticleId IdType="pubmed">17108030</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Mol Immunol. 2005 Apr;2(2):101-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16191415</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2008 Jun;82(11):5279-94</Citation><ArticleIdList><ArticleId IdType="pubmed">18367524</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunology. 2003 Jul;109(3):326-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12807475</ArticleId></ArticleIdList></Reference><Reference><Citation>DNA Res. 2010 Jun;17(3):155-68</Citation><ArticleIdList><ArticleId IdType="pubmed">20360268</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Opin Ther Pat. 2009 Apr;19(4):415-31</Citation><ArticleIdList><ArticleId IdType="pubmed">19441924</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Chem. 2007 Aug 23;50(17):4087-95</Citation><ArticleIdList><ArticleId IdType="pubmed">17663539</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Anti Infect Ther. 2006 Apr;4(2):291-302</Citation><ArticleIdList><ArticleId IdType="pubmed">16597209</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10012-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15226499</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2005;7:7482-5</Citation><ArticleIdList><ArticleId IdType="pubmed">17282011</ArticleId></ArticleIdList></Reference><Reference><Citation>Viral Immunol. 2007 Spring;20(1):197-205</Citation><ArticleIdList><ArticleId IdType="pubmed">17425434</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Cell Mol Biol. 2008 Aug;39(2):142-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18314540</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2008 Jun 3;105(22):7809-14</Citation><ArticleIdList><ArticleId IdType="pubmed">18490652</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2008 Apr 25;374(1):151-63</Citation><ArticleIdList><ArticleId IdType="pubmed">18234270</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001494 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001494 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:21765859
|texte= Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:21765859" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |